OpenAI has invested in Isara, an AI startup valued at $650 million after raising $94 million. Founded by a 23-year-old, Isara develops software to coordinate thousands of AI agents for complex tasks in finance and biotechnology. Investors include Michael Ovitz and Stanley Druckenmiller. The company plans to target investment firms with its predictive modeling tools, having already tested a system with 2,000 agents forecasting gold prices. Altcoins to watch may respond as the Fear & Greed Index indicates rising institutional interest in AI-driven markets.

ChainCatcher report, according to The Wall Street Journal, OpenAI has invested in Isara, an AI startup founded by two 23-year-old researchers aiming to develop software that coordinates thousands of AI agents to collaborate on complex problems in finance, biotechnology, and other fields. Isara recently raised $94 million at a $650 million valuation, with investors including Michael Ovitz and Stanley Druckenmiller, alongside OpenAI. The founders co-authored an academic paper in June last year proposing the use of collaborative AI systems to improve policymaking. The company has already recruited around 12 researchers from Google, Meta, and OpenAI. Isara plans to initially sell its software to investment firms for predictive modeling and has demonstrated the ability to coordinate approximately 2,000 AI agents to predict gold prices.Source:Show originalDisclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.